Nisa Investment Advisors LLC Sells 14,649 Shares of Centene Co. (NYSE:CNC)

Nisa Investment Advisors LLC trimmed its position in shares of Centene Co. (NYSE:CNCFree Report) by 6.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 205,437 shares of the company’s stock after selling 14,649 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Centene were worth $12,445,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of CNC. Park Place Capital Corp grew its holdings in shares of Centene by 1,190.0% during the third quarter. Park Place Capital Corp now owns 387 shares of the company’s stock valued at $29,000 after buying an additional 357 shares during the last quarter. Private Trust Co. NA boosted its stake in Centene by 75.3% during the 3rd quarter. Private Trust Co. NA now owns 773 shares of the company’s stock valued at $58,000 after purchasing an additional 332 shares during the last quarter. True Wealth Design LLC bought a new stake in shares of Centene in the 3rd quarter worth $66,000. Venturi Wealth Management LLC lifted its holdings in shares of Centene by 77.3% during the third quarter. Venturi Wealth Management LLC now owns 1,163 shares of the company’s stock valued at $88,000 after purchasing an additional 507 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its position in shares of Centene by 104.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,231 shares of the company’s stock valued at $82,000 after buying an additional 630 shares during the last quarter. 93.63% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the stock. StockNews.com cut shares of Centene from a “strong-buy” rating to a “buy” rating in a research note on Monday, October 28th. Sanford C. Bernstein dropped their target price on shares of Centene from $96.00 to $88.00 and set an “outperform” rating on the stock in a report on Wednesday, October 30th. Robert W. Baird decreased their target price on shares of Centene from $83.00 to $66.00 and set a “neutral” rating for the company in a research note on Friday, October 25th. JPMorgan Chase & Co. restated an “overweight” rating and issued a $75.00 price target (down from $80.00) on shares of Centene in a research note on Tuesday, December 17th. Finally, Wells Fargo & Company lowered their target price on Centene from $91.00 to $90.00 and set an “overweight” rating on the stock in a report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Centene presently has a consensus rating of “Moderate Buy” and a consensus target price of $80.92.

Check Out Our Latest Stock Analysis on CNC

Insider Buying and Selling

In other Centene news, CFO Andrew Lynn Asher bought 17,200 shares of the business’s stock in a transaction that occurred on Wednesday, November 13th. The stock was purchased at an average price of $58.14 per share, for a total transaction of $1,000,008.00. Following the completion of the transaction, the chief financial officer now owns 486,847 shares of the company’s stock, valued at $28,305,284.58. This trade represents a 3.66 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Sarah London purchased 4,117 shares of the stock in a transaction that occurred on Friday, November 8th. The stock was acquired at an average cost of $60.80 per share, for a total transaction of $250,313.60. Following the completion of the acquisition, the chief executive officer now owns 667,229 shares in the company, valued at $40,567,523.20. This represents a 0.62 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders bought 45,010 shares of company stock valued at $2,660,276. Company insiders own 0.33% of the company’s stock.

Centene Stock Performance

CNC opened at $65.15 on Friday. The firm has a market cap of $32.89 billion, a P/E ratio of 11.31, a PEG ratio of 0.85 and a beta of 0.45. Centene Co. has a 1-year low of $55.03 and a 1-year high of $81.42. The company has a 50 day simple moving average of $60.36 and a two-hundred day simple moving average of $67.26. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10.

Centene Company Profile

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Read More

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNCFree Report).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.